The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
David Ricks, CEO of the Indiana drugmaker, has cut deals with the president to slash prices and build American. Trump has ...
Join us as we explore Eli Lilly's impressive market position and financial health. Discover why this pharmaceutical giant is ...
Lilly has launched six early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel targets.
Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.
Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...
Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...
Eli Lilly highlighted 2025 as the rollout year for obesity drugs, with Mounjaro at the forefront of its weight-loss portfolio ...
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...
A compounding pharmacy has filed a lawsuit accusing Eli Lilly and Novo Nordisk of using anticompetitive tactics to prevent it ...
France's Finance Ministry said on Monday it had received no formal request for investment approval regarding French biotech ...
The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results